Tokyo, Japan

Namiko Yamashita

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Namiko Yamashita: Advancing Cancer Detection

Introduction

Namiko Yamashita, an accomplished inventor from Tokyo, Japan, has made significant strides in the field of cancer research and diagnostics. With a unique patent to her name, she is dedicated to enhancing the accuracy of cancer progression assessment and malignancy detection, ultimately improving patient outcomes.

Latest Patents

Yamashita holds a notable patent for an "Apparatus for detecting the degree of malignancy of each of circulating tumor cells." This groundbreaking invention aims to provide a reliable evaluation method that can accurately determine cancer metastasis, stage of progression, and malignancy levels. The patented method involves a series of steps that utilize fluorescently-labeled or luminescent enzyme-labeled components, enabling the detection of circulating tumor cells with precision. By analyzing fluorescence and luminescence signals, her invention can determine the degree of epithelial-mesenchymal transition of these cells.

Career Highlights

Throughout her career, Namiko Yamashita has worked with various prominent organizations, including On-chip Biotechnologies Co., Ltd. and the Shizuoka Prefecture. These experiences have allowed her to collaborate with talented colleagues, further advancing her research and innovations in cancer diagnostics.

Collaborations

Yamashita has had the opportunity to work alongside esteemed professionals such as Kazuo Takeda and Yuu Fujimura. Their collaboration has fostered a dynamic exchange of ideas, enhancing the impact of her work in cancer detection technologies.

Conclusion

Namiko Yamashita stands out as a pioneering inventor dedicated to revolutionizing the field of cancer diagnostics. Her innovative approach to detecting the malignancy of circulating tumor cells has the potential to transform how cancer progression is assessed, ultimately benefiting countless patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…